David Altshuler, EVP, Global Research and CSO: Vertex Pharmaceuticals VRTX Sell · Filed 24/02/23

Trade details

Type: Insider sale
Amount: $1,266,153.54
Shares · price: 3,002 sh · $421.77 a share
Held after: 34,022 sh
Stock: Vertex Pharmaceuticals VRTX
Person: David AltshulerEVP, Global Research and CSO
Trade date: 24/02/21
Filed: 24/02/23
Days to filing: 2 days

Sold 8.1% of holdings

Share of holding sold: 8.1%

Vertex Pharmaceuticals trades, last 26 weeks

What else happened in Vertex Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/01/22~24/03/22

David Altshuler's recent trades

David AltshulerEVP, Chief Scientific Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$22.1K
52 sh
$22.1K
Filed 25/05/19
Traded 25/05/15
David AltshulerEVP, Chief Scientific Officer
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 plan
Vertex Pharmaceuticals
VRTX
$22.1K
52 sh
$22.1K
Filed 25/05/15
Traded 25/05/15
David AltshulerEVP, Chief Scientific Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.6M
3,231 sh
$1.6M
Filed 25/03/17
Traded 25/03/13
David AltshulerEVP, Global Research and CSO
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.6M
3,231 sh
$1.6M
Filed 25/03/13
Traded 25/03/13
David AltshulerEVP, Chief Scientific Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.6M
3,231 sh
$1.6M
Filed 25/03/12
Traded 25/03/10